162 related articles for article (PubMed ID: 25899580)
1. Thyroid function, as assessed by TSH, and future risk of venous thromboembolism: the Tromsø study.
Lerstad G; Enga KF; Jorde R; Brodin EE; Svartberg J; Brækkan SK; Hansen JB
Eur J Endocrinol; 2015 Jul; 173(1):83-90. PubMed ID: 25899580
[TBL] [Abstract][Full Text] [Related]
2. Associations between serum levels of calcium, parathyroid hormone and future risk of venous thromboembolism: the Tromsø study.
Lerstad G; Brodin EE; Svartberg J; Jorde R; Brox J; Brækkan SK; Hansen JB
Eur J Endocrinol; 2017 May; 176(5):625-634. PubMed ID: 28246149
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of vitamin D are not associated with future risk of venous thromboembolism. The Tromsø Study.
Brodin E; Lerstad G; Grimnes G; Brækkan SK; Vik A; Brox J; Svartberg J; Jorde R; Hansen JB
Thromb Haemost; 2013 May; 109(5):885-90. PubMed ID: 23446951
[TBL] [Abstract][Full Text] [Related]
4. Heart healthy diet and risk of myocardial infarction and venous thromboembolism. The Tromsø Study.
Hansen-Krone IJ; Enga KF; Njølstad I; Hansen JB; Braekkan SK
Thromb Haemost; 2012 Sep; 108(3):554-60. PubMed ID: 22739999
[TBL] [Abstract][Full Text] [Related]
5. COPD and risk of venous thromboembolism and mortality in a general population.
Børvik T; Brækkan SK; Enga K; Schirmer H; Brodin EE; Melbye H; Hansen JB
Eur Respir J; 2016 Feb; 47(2):473-81. PubMed ID: 26585434
[TBL] [Abstract][Full Text] [Related]
6. Ischemic Stroke and Risk of Venous Thromboembolism in the General Population: The Tromsø Study.
Rinde LB; Småbrekke B; Mathiesen EB; Løchen ML; Njølstad I; Hald EM; Wilsgaard T; Brækkan SK; Hansen JB
J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27821402
[TBL] [Abstract][Full Text] [Related]
7. Body height and risk of venous thromboembolism: The Tromsø Study.
Braekkan SK; Borch KH; Mathiesen EB; Njølstad I; Wilsgaard T; Hansen JB
Am J Epidemiol; 2010 May; 171(10):1109-15. PubMed ID: 20418276
[TBL] [Abstract][Full Text] [Related]
8. Carotid atherosclerosis predicts future myocardial infarction but not venous thromboembolism: the Tromso study.
Hald EM; Lijfering WM; Mathiesen EB; Johnsen SH; Løchen ML; Njølstad I; Wilsgaard T; Rosendaal FR; Brækkan SK; Hansen JB
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):226-30. PubMed ID: 24177328
[TBL] [Abstract][Full Text] [Related]
9. Red cell distribution width is associated with incident venous thromboembolism (VTE) and case-fatality after VTE in a general population.
Ellingsen TS; Lappegård J; Skjelbakken T; Brækkan SK; Hansen JB
Thromb Haemost; 2015 Jan; 113(1):193-200. PubMed ID: 25274492
[TBL] [Abstract][Full Text] [Related]
10. Sleep disorders increase the risk of venous thromboembolism in individuals without sleep apnea: a nationwide population-based cohort study in Taiwan.
Chung WS; Chen YF; Lin CL; Chang SN; Hsu WH; Kao CH
Sleep Med; 2015 Jan; 16(1):168-72. PubMed ID: 25547034
[TBL] [Abstract][Full Text] [Related]
11. Endogenous sex hormone levels in men are not associated with risk of venous thromboembolism: the Tromso study.
Svartberg J; Braekkan SK; Laughlin GA; Hansen JB
Eur J Endocrinol; 2009 May; 160(5):833-8. PubMed ID: 19208774
[TBL] [Abstract][Full Text] [Related]
12. Impact of incident venous thromboembolism on risk of arterial thrombotic diseases.
Lind C; Flinterman LE; Enga KF; Severinsen MT; Kristensen SR; Braekkan SK; Mathiesen EB; Njølstad I; Cannegieter SC; Overvad K; Hansen JB
Circulation; 2014 Feb; 129(8):855-63. PubMed ID: 24270266
[TBL] [Abstract][Full Text] [Related]
13. Impact of incident myocardial infarction on the risk of venous thromboembolism: the Tromsø Study.
Rinde LB; Lind C; Småbrekke B; Njølstad I; Mathiesen EB; Wilsgaard T; Løchen ML; Hald EM; Vik A; Braekkan SK; Hansen JB
J Thromb Haemost; 2016 Jun; 14(6):1183-91. PubMed ID: 27061154
[TBL] [Abstract][Full Text] [Related]
14. Atrial fibrillation and future risk of venous thromboembolism:the Tromsø study.
Enga KF; Rye-Holmboe I; Hald EM; Løchen ML; Mathiesen EB; Njølstad I; Wilsgaard T; Braekkan SK; Hansen JB
J Thromb Haemost; 2015 Jan; 13(1):10-6. PubMed ID: 25330989
[TBL] [Abstract][Full Text] [Related]
15. Venous thromboembolism and subsequent permanent work-related disability.
Braekkan SK; Grosse SD; Okoroh EM; Tsai J; Cannegieter SC; Naess IA; Krokstad S; Hansen JB; Skjeldestad FE
J Thromb Haemost; 2016 Oct; 14(10):1978-1987. PubMed ID: 27411161
[TBL] [Abstract][Full Text] [Related]
16. Weight Change and Risk of Venous Thromboembolism: The Tromsø Study.
Horvei LD; Brækkan SK; Hansen JB
PLoS One; 2016; 11(12):e0168878. PubMed ID: 27997594
[TBL] [Abstract][Full Text] [Related]
17. Repeated measurements of carotid atherosclerosis and future risk of venous thromboembolism: the Tromsø Study.
Småbrekke B; Rinde LB; Hald EM; Njølstad I; Mathiesen EB; Johnsen SH; Hansen JB; Braekkan SK; Lijfering WM
J Thromb Haemost; 2017 Dec; 15(12):2344-2351. PubMed ID: 28981216
[TBL] [Abstract][Full Text] [Related]
18. Hyperglycemia, assessed according to HbA1c , and future risk of venous thromboembolism: the Tromsø study.
Lerstad G; Brodin EE; Enga KF; Jorde R; Schirmer H; Njølstad I; Svartberg J; Braekkan SK; Hansen JB
J Thromb Haemost; 2014; 12(3):313-9. PubMed ID: 24382156
[TBL] [Abstract][Full Text] [Related]
19. Thyroid-stimulating hormone concentration as an independent risk factor of venous thromboembolism regardless of thyroid function.
Kovářová M; Koller T; Štvrtinová V; Payer J
Endokrynol Pol; 2015; 66(6):474-9. PubMed ID: 26662645
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism increases the risk of atrial fibrillation: the Tromso study.
Hald EM; Enga KF; Løchen ML; Mathiesen EB; Njølstad I; Wilsgaard T; Braekkan SK; Hansen JB
J Am Heart Assoc; 2014 Jan; 3(1):e000483. PubMed ID: 24385452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]